Richard de Goeij-de Haas

Author

Also Known As

R. Haas, R. de Haas, RICHARD HAAS, Richard D. Haas, Richard Haas, Richard Haas⁎, Richard de Goeij-de Haas, Richard de Haas, de Goeij-de Haas, Richard

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam Amsterdam University Medical Centers The Netherlands Cancer Institute University Medical Center Freiburg Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Richard de Goeij-de Haas is an author at Vrije Universiteit Amsterdam specializing in tumor biology, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	438
2	Pathology	3	3	438
3	Cell Biology	2	2	420
4	Pharmacology	2	2	44
5	Cancer Cell Biology	2	2	412

Richard de Goeij-de Haas

Publications

Citations

H-Index

Page 1

	Year	Citations
Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function Marion Krieg, Richard de Goeij-de Haas, Hiltrud Brauch, Oncogene Hypoxia-inducible Factors Hif-1αRedox RegulatorMedicineHypoxia (Medicine)Pathology	2000	394
Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling Frederik J. Verweij, Maarten P. Bebelman, Connie R. Jiménez, The Journal of Cell Biology	2018	350
Putative Control of Angiogenesis in Hemangioblastomas by the von Hippel-Lindau Tumor Suppressor Gene Rembert Stratmann, Marion Krieg, Richard de Goeij-de Haas, Journal of Neuropathology & Experimental Neurology	1997	82
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma Tessa Y. S. Le Large, Maarten F. Bijlsma, Btissame El Hassouni, Journal of Experimental & Clinical Cancer Research	2021	53
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer Robin Beekhof, Andrea Bertotti, Franziska Böttger, Science Translational Medicine Chemoprevention StrategyMedicineReceptor Tyrosine KinasePharmacologyColorectal Cancer	2023	26
Oxidative Metabolism in Rett Syndrome: 1. Clinical Studies Richard de Goeij-de Haas, Merle R. Light, MAUREEN J. RICE, Neuropediatrics	1995	25
VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients Laura Vroling, Yuana Yuana, Gerrit Jan Schuurhuis, Thrombosis and Haemostasis	2007	22
EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy Maike Schuldt, Emmy Manders, Valentijn Jansen, Circulation Research	2023	19
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome Mariëtte Labots, Thang V. Pham, Richard J. Honeywell, Cancers Chemoprevention StrategyPathologyTumor BiologyPre-clinical PharmacologyAdvanced Cancer Results	2020	18
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment Judy R. van Beijnum, Andrea Weiss, Robert H. Berndsen, Cancers	2020	18

Page 1